Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 inProteus mirabilisin humans and dogs in France, 2010–13

The complete sequence of Salmonella genomic island SGI2

(2014) M. Hamidian et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate

(2014) Delphine Girlich et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates

(2014) E. Siebor et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Prevalence of Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae in Poultry Meat in Switzerland: Emergence of CMY-2- and VEB-6-Possessing Proteus mirabilis

(2013) Salome N. Seiffert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France

(2013) Eliane Siebor et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region

(2011) Eliane Siebor et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Salmonellagenomic islands and antibiotic resistance inSalmonella enterica

(2010) Ruth M Hall   Future Microbiology

European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O

(2010) Benoît Doublet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Salmonella Genomic Island 1 Is Specifically Mobilized In Trans by the IncA/C Multidrug Resistance Plasmid Family

(2010) Gregory Douard et al.   PLoS One

SGI2, a Relative of Salmonella Genomic Island SGI1 with an Independent Origin

(2008) R. S. Levings et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY